Their use should be limited to clear medical indicationstype 2 diabetes, obesity, insulin resistance, or elevated cardiometabolic riskand always integrated into a care plan that considers a womans reproductive goals, hormonal therapies, and individual symptom profile
The efficacy of lipoic acid, administered either intravenously or orally, in the management of neuropathic symptoms has been examined in patients with diabetes
Kalaria R (2002) Small vessel disease and Alzheimers dementia: pathological considerations
In a cohort of ASD patients in China, Clostridium, Streptococcus, Acinetobacter , and Alcaligenaceae were enriched in ASD patients, along with arginase metabolism, which has been proposed as a biomarker for ASD [305]
Addadi, R
Start with the systemic approachit's effective, safe, and often all that's needed